Tambaro, Simone
Mitra, Sumonto
Gera, Ruchi
Linderoth, Bengt
Wahlberg, Lars U.
Darreh-Shori, Taher
Behbahani, Homira
Nilsson, Per
Eriksdotter, Maria
Funding for this research was provided by:
Karolinska Institutet Research Fund
Loo and Hans Osterman Foundation
Foundation for Geriatric Diseases at Karolinska Institutet
Gamla Tjänarinnor
Stohnes Stiftelse
Åhléns foundation
Demensfonden
Ake Weiberg Foundation
Olle Engkvist Foundation
Magnus Bergvall foundation
ALF Medicine Stockholm
Hållsten Research Foundation (2-511512017)
Torsten Söderbergs Stiftelse (M152/19)
Sonja Leikrans donation (05203)
Alzheimerfonden (AF-979593)
Hjärnfonden (FO2022-0344)
Vetenskapsrådet (2020-02014)
Swedish Brain Foundation
Familjen Erling-Perssons Stiftelse
Karolinska Institute
Article History
Received: 30 January 2023
Accepted: 29 July 2023
First Online: 18 August 2023
Declarations
:
: All animal experiments were carried out under the ethical permits ID 407 approved by Linköping animal ethical board, 12570–2021 and 5406–2020 approved by Stockholm animal ethical board.
: Not applicable.
: LUW is an employee and shareholder of Gloriana Therapeutics, Inc., and Sinfonia Biotherapeutics AB. Other authors declare that they have no competing interest.